UK markets closed

Spectrum Pharmaceuticals, Inc. (SPPI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.8800-0.0105 (-1.18%)
At close: 04:00PM EDT
0.8800 0.00 (0.00%)
After hours: 07:24PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 149.47M
Enterprise value 61.26M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.71
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.48

Trading information

Stock price history

Beta (5Y monthly) 2.23
52-week change 3-77.61%
S&P500 52-week change 3-8.83%
52-week high 34.0300
52-week low 30.6000
50-day moving average 30.8320
200-day moving average 31.2981

Share statistics

Avg vol (3-month) 32.36M
Avg vol (10-day) 34.29M
Shares outstanding 5180.09M
Implied shares outstanding 6N/A
Float 8140.96M
% held by insiders 19.77%
% held by institutions 140.94%
Shares short (30 May 2022) 412.75M
Short ratio (30 May 2022) 47.11
Short % of float (30 May 2022) 47.14%
Short % of shares outstanding (30 May 2022) 47.08%
Shares short (prior month 28 Apr 2022) 411.77M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 327 Dec 2012
Ex-dividend date 417 Dec 2012
Last split factor 21:25
Last split date 305 Sept 2002

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-55.18%
Return on equity (ttm)-155.51%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -122.89M
Net income avi to common (ttm)-138.16M
Diluted EPS (ttm)-0.8600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)89.21M
Total cash per share (mrq)0.51
Total debt (mrq)2.3M
Total debt/equity (mrq)4.16
Current ratio (mrq)2.38
Book value per share (mrq)0.32

Cash flow statement

Operating cash flow (ttm)-115.29M
Levered free cash flow (ttm)-63.61M